Literature DB >> 12906033

Relationship between impaired chronotropic response, cardiac output during exercise, and exercise tolerance in patients with chronic heart failure.

Hisanori Samejima1, Kazuto Omiya, Masato Uno, Kohji Inoue, Masachika Tamura, Kae Itoh, Kengo Suzuki, Yoshihiro Akashi, Atsushi Seki, Noriyuki Suzuki, Naohiko Osada, Kazuhiko Tanabe, Fumihiko Miyake, Haruki Itoh.   

Abstract

The present study was undertaken to investigate the relationship between the extent of impaired chronotropic response and cardiac output during exercise, and exercise tolerance in patients with chronic heart failure. The subjects consisted of 24 patients (mean 60.1 +/- 14.0 years) who had mild chronotropic incompetence. Cardiopulmonary exercise testing was performed in all patients, and heart rate (HR), anaerobic threshold (AT), maximum oxygen uptake (peak VO2), slope of the regression line relating the ventilatory equivalent to carbon dioxide output (VE/VCO2 slope), and exercise time were measured. Cardiac output (CO) was measured by a thoracic bioimpedance method and cardiac index (CI) was calculated. Plasma norepinephrine (NE) was measured at rest and immediately after the exercise test. The changes in HR, NE, and CI from the resting state to immediately after exercise were calculated as deltaHR, deltaNE, and deltaCI, respectively. The deltaNE was converted to a logarithmic scale and deltaHR/log deltaNE was used as a parameter of HR response to sympathetic nerve stimulation. The results were as follows: HR and NE in the resting state had no correlation with AT and with peak VO2. DeltaHR/log deltaNE correlated positively with both AT and peak VO2, and negatively with the VE/CO2 slope. DeltaHR/log deltaNE correlated positively with peak CI, %deltaCI, and deltaCI/exercise time. The data suggest that one of the mechanisms of low exercise tolerance in chronic heart failure patients was due to an inadequate increase in CO response against exercise caused by an impaired HR response to increased NE.

Entities:  

Mesh:

Year:  2003        PMID: 12906033     DOI: 10.1536/jhj.44.515

Source DB:  PubMed          Journal:  Jpn Heart J        ISSN: 0021-4868


  9 in total

1.  Chronic heart failure, chronotropic incompetence, and the effects of beta blockade.

Authors:  K K A Witte; J G F Cleland; A L Clark
Journal:  Heart       Date:  2005-09-13       Impact factor: 5.994

Review 2.  Prevalence and management of chronotropic incompetence in heart failure.

Authors:  Peter H Brubaker; Dalane W Kitzman
Journal:  Curr Cardiol Rep       Date:  2007-05       Impact factor: 2.931

3.  Heart rate response and functional capacity in patients with chronic heart failure with preserved ejection fraction.

Authors:  Eloy Domínguez; Patricia Palau; Eduardo Núñez; José María Ramón; Laura López; Joana Melero; Alejandro Bellver; Enrique Santas; Francisco J Chorro; Julio Núñez
Journal:  ESC Heart Fail       Date:  2018-03-24

4.  Association between resting heart rate, chronotropic index, and long-term outcomes in patients with heart failure receiving β-blocker therapy: data from the HF-ACTION trial.

Authors:  Daniela Dobre; Faiez Zannad; Steven J Keteyian; Susanna R Stevens; Patrick Rossignol; Dalane W Kitzman; Joel Landzberg; Jonathan Howlett; William E Kraus; Stephen J Ellis
Journal:  Eur Heart J       Date:  2013-01-12       Impact factor: 29.983

5.  Chronotropy: the Cinderella of heart failure pathophysiology and management.

Authors:  Peter H Brubaker; Dalane W Kitzman
Journal:  JACC Heart Fail       Date:  2013-06-03       Impact factor: 12.035

Review 6.  Relationships among norepinephrine levels, exercise capacity, and chronotropic responses in heart failure patients.

Authors:  Liza Grosman-Rimon; Evan Wright; Solomon Sabovich; Jordan Rimon; Sagi Gleitman; Doron Sudarsky; Alla Lubovich; Itzhak Gabizon; Spencer D Lalonde; Sharon Tsuk; Michael A McDonald; Vivek Rao; David Gutterman; Ulrich P Jorde; Shemy Carasso; Erez Kachel
Journal:  Heart Fail Rev       Date:  2022-03-24       Impact factor: 4.214

Review 7.  Chronotropic incompetence: causes, consequences, and management.

Authors:  Peter H Brubaker; Dalane W Kitzman
Journal:  Circulation       Date:  2011-03-08       Impact factor: 39.918

Review 8.  Could SGLT2 Inhibitors Improve Exercise Intolerance in Chronic Heart Failure?

Authors:  Suzanne N Voorrips; Huitzilihuitl Saucedo-Orozco; Pablo I Sánchez-Aguilera; Rudolf A De Boer; Peter Van der Meer; B Daan Westenbrink
Journal:  Int J Mol Sci       Date:  2022-08-03       Impact factor: 6.208

9.  Silencing miR-370-3p rescues funny current and sinus node function in heart failure.

Authors:  Joseph Yanni; Alicia D'Souza; Yanwen Wang; Ning Li; Brian J Hansen; Stanislav O Zakharkin; Matthew Smith; Christina Hayward; Bryan A Whitson; Peter J Mohler; Paul M L Janssen; Leo Zeef; Moinuddin Choudhury; Min Zi; Xue Cai; Sunil Jit R J Logantha; Shu Nakao; Andrew Atkinson; Maria Petkova; Ursula Doris; Jonathan Ariyaratnam; Elizabeth J Cartwright; Sam Griffiths-Jones; George Hart; Vadim V Fedorov; Delvac Oceandy; Halina Dobrzynski; Mark R Boyett
Journal:  Sci Rep       Date:  2020-07-09       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.